Dianthus Therapeutics, Inc. · NASDAQ:DNTH
T. Rowe Price Investment Management, Inc. reported a 12.10% stake in Dianthus Therapeutics, Inc. (Schedule 13G/A)
Event Jul 31, 2026 · Filed Aug 7, 2026
T. Rowe Price Investment Management, Inc. reported a 12.10% stake in Dianthus Therapeutics, Inc., 6,632,303 shares, as a passive investor on Jul 31, 2026. Filed Aug 7, 2026 (Schedule 13G/A).
- Stake
- 12.10%
- Shares
- 6,632,303
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 12.10% | 6,632,303 |
Source
Related
- Dianthus Therapeutics, Inc.
- T. Rowe Price Investment Management, Inc.
- Dianthus Therapeutics, Inc. shareholders
- Schedule 13G · T. Rowe Price Investment Management, Inc. · Aug 7, 2026
- Form 4 · Carr Edward · Sep 18, 2026
- Form 4 · Randhawa Simrat · Sep 3, 2026
- Form 4 · Read Simon · Aug 19, 2026
- Form 4 · Veness Adam M · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026